0000899243-19-015912.txt : 20190606 0000899243-19-015912.hdr.sgml : 20190606 20190606210238 ACCESSION NUMBER: 0000899243-19-015912 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190604 FILED AS OF DATE: 20190606 DATE AS OF CHANGE: 20190606 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kemmerly David L CENTRAL INDEX KEY: 0001673554 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-24260 FILM NUMBER: 19884013 MAIL ADDRESS: STREET 1: 3854 AMERICAN WAY STREET 2: SUITE A CITY: BATON ROUGE STATE: LA ZIP: 70816 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AMEDISYS INC CENTRAL INDEX KEY: 0000896262 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HOME HEALTH CARE SERVICES [8082] IRS NUMBER: 113131700 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3854 AMERICAN WAY STREET 2: SUITE A CITY: BATON ROUGE STATE: LA ZIP: 70816 BUSINESS PHONE: 2252922031 MAIL ADDRESS: STREET 1: 3854 AMERICAN WAY STREET 2: SUITE A CITY: BATON ROUGE STATE: LA ZIP: 70816 FORMER COMPANY: FORMER CONFORMED NAME: ANALYTICAL NURSING MANAGEMENT CORP DATE OF NAME CHANGE: 19940819 FORMER COMPANY: FORMER CONFORMED NAME: M&N CAPITAL CORP DATE OF NAME CHANGE: 19930125 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-06-04 0 0000896262 AMEDISYS INC AMED 0001673554 Kemmerly David L 3854 AMERICAN WAY, SUITE A BATON ROUGE LA 70816 0 1 0 0 See Remarks Common Stock 2019-06-04 4 F 0 1640 113.49 D 20884 D Common Stock 2019-06-04 4 F 0 410 113.49 D 20474 D Common Stock 2019-06-04 4 F 0 411 113.49 D 20063 D Common Stock 2019-06-04 4 F 0 411 113.49 D 19652 D Common Stock 2019-06-06 4 S 0 4420 113.40 D 15232 D Common Stock 445 I Through 401(k) Plan The total amount of shares beneficially owned includes 219 shares held in an employee stock purchase plan account. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $113.13 to $113.73, inclusive. The reporting person undertakes to provide to Amedisys, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. The information in this report is based on a plan statement dated as of March 31, 2019. General Counsel and Senior Vice President of Government Affairs /s/ Jennifer R. Guckert, pursuant to a power of attorney 2019-06-06